Plastic particles in medicine: A systematic review of exposure and effects to human health.

Single-use plastics (SUPs) have become an essential constituent of our daily life. It is being exploited in numerous pharmaceutical and healthcare applications. Despite their advantages and widespread use in the pharma and medical sectors, the potential clinical problems of plastics, especially the release of micro-nanoplastics (MNPs) and additives from medical plastics (e.g. bags, containers, and administrative sets) and sorption of drugs remain understudied. Certainly, the MNPs are multifaceted stressors that cause detrimental effects to the ecosystem and human health. The origin and persistence of MNPs in pharmaceutical products, their administration to humans, endurance and possible health implication, translocation, and excretion have not been reviewed in detail. The prime focus of this article is to conduct a systematic review on the leaching of MNPs and additives from pharmaceutical containers/administrative sets and their interaction with the pharmaceutical constituents. This review also explores the primary and secondary routes of MNPs entry from healthcare plastic products and their potential health hazards to humans. Furthermore, the fate of plastic waste generated in hospitals, their disposal, and associated MNPs release to the environment, along with preventive, and alternative measures are discussed herein. [Display omitted] • Leaching of micro/nano plastics (MNPs) from the pharmaceuticals containers and administrative sets were discussed in detail. • Mechanisms of interaction of pharmaceutical constituents with MNPs and additives were reviewed. • Ingestion, inhalation, infusion and dermal routes of MNPS/additives administration were described. • Accumulation, translocation and excretion of MNPs/additives and toxic effects on various organs and tissues were discussed. [ABSTRACT FROM AUTHOR]